Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check11 days agoChange DetectedEnrollment status updated to 'No longer looking for participants,' indicating recruitment is closed. New navigation items and labels (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) were added, existing label formatting was adjusted, and the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check18 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a minor site update. There are no visible changes to the study details or layout.SummaryDifference0.0%

- Check39 days agoChange DetectedNew page revision v3.5.4 was added, replacing the previous v3.5.3. This indicates a routine maintenance update to the page’s revision history rather than a content change.SummaryDifference0.0%

- Check46 days agoChange DetectedThe Taiwan site listing was refined from 'Taoyuan, Taiwan, 33004' to 'Taoyuan City, Taiwan, 33004', clarifying the exact city designation while preserving the postal code.SummaryDifference0.0%

- Check53 days agoChange DetectedThe revision label was updated from v3.5.2 to v3.5.3, indicating a new version of the page's documentation. This reflects an incremental update to the page's revision history rather than a change to substantive content.SummaryDifference0.0%

- Check68 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.